“The existing predicament has uncovered some structural weaknesses during the EU’s medicines source chain and a superior dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She advisable that offer chain troubles be tackled within an EU pharmaceutical system expecte